Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.
肠道细菌酪氨酸脱羧酶限制左旋多巴的水平，从而影响帕金森病的治疗
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-019-08294-y
van Kessel Sebastiaan P, Frye Alexandra K, El-Gendy Ahmed O, Castejon Maria, Keshavarzian Ali, van Dijk Gertjan, El Aidy Sahar
